MoonLake Immunotherapeutics (MLTX)
45.26
+2.69
(+6.32%)
USD |
NASDAQ |
May 03, 16:00
45.23
-0.03
(-0.07%)
After-Hours: 20:00
MoonLake Immunotherapeutics Total Assets (Quarterly): 526.54M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 526.54M |
| September 30, 2023 | 500.22M |
| June 30, 2023 | 506.62M |
| March 31, 2023 | 66.80M |
| Date | Value |
|---|---|
| December 31, 2022 | 76.84M |
| September 30, 2022 | 88.59M |
| June 30, 2022 | 98.43M |
| December 31, 2021 | 9.682M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
9.682M
Minimum
Dec 2021
526.54M
Maximum
Dec 2023
234.22M
Average
93.51M
Median
Total Assets (Quarterly) Benchmarks
| Qiagen NV | 5.806B |
| LENZ Therapeutics Inc | -- |
| AC Immune SA | 217.65M |
| CRISPR Therapeutics AG | 2.230B |
| Addex Therapeutics Ltd | 5.526M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 13.05M |
| Shareholders Equity (Quarterly) | 495.68M |